Mark Genovese

Mark Genovese

Corporate Officer/Principal at ELI LILLY AND COMPANY
Health Technology
Consumer Services

Profile

Mark Genovese is currently the Senior Vice President-Immunology Development at Eli Lilly & Co. He previously worked as the Director at Kyverna Therapeutics, Inc. and as the Clinical Chief-Immunology & Rheumatology at Stanford University.
From 2020 to 2023, he served as the Senior Vice President-Inflammation Development at Gilead Sciences, Inc. Dr. Genovese completed his undergraduate degree at the University of Notre Dame and obtained his doctorate from The Johns Hopkins University School of Medicine.

Mark Genovese active positions

CompaniesPositionStart
ELI LILLY AND COMPANY Corporate Officer/Principal 2023-10-15

Former positions of Mark Genovese

CompaniesPositionEnd
GILEAD SCIENCES, INC. Corporate Officer/Principal 2023-08-31
KYVERNA THERAPEUTICS, INC. Director/Board Member -
Corporate Officer/Principal -
See the detail of Mark Genovese's experience

Training of Mark Genovese

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

21

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology